Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0DW1D
|
|||
| Drug Name |
PMID30185082-Compound-57
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
THE UNIVERSITY OF MISSISSIPPI THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H25FN2OS
|
|||
| Canonical SMILES |
C1CCCN(CC1)CCN2C3=C(C=C(C=C3)CCCF)SC2=O
|
|||
| InChI |
1S/C18H25FN2OS/c19-9-5-6-15-7-8-16-17(14-15)23-18(22)21(16)13-12-20-10-3-1-2-4-11-20/h7-8,14H,1-6,9-13H2
|
|||
| InChIKey |
DNGYIBDXSUNKMV-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1350296-21-7
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Opioid receptor sigma 1 (OPRS1) | Target Info | Ligand | [1] |
| Sigma intracellular receptor 2 (TMEM97) | Target Info | Ligand | [1] | |
| Target's Patent Info | Opioid receptor sigma 1 (OPRS1) | Target's Patent Info | [1] | |
| Sigma intracellular receptor 2 (TMEM97) | Target's Patent Info | [1] | ||
| WikiPathways | miR-targeted genes in squamous cell - TarBase | |||
| miR-targeted genes in lymphocytes - TarBase | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The sigma-2 (-2) receptor: a review of recent patent applications: 2013-2018.Expert Opin Ther Pat. 2018 Sep;28(9):655-663. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.